Navigation Links
Contrasting Reimbursement Environments Result in Different Prescribing Patterns for Premium-Priced Therapies in China and South Korea
Date:11/25/2013

BURLINGTON, Mass., Nov. 25, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in China, a combination of government restrictions on reimbursement and regional variations in formulary coverage heavily influence the use of premium-priced targeted therapies in the breast cancer drug market.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36784LOGO)

Decision Resources' new Emerging Markets Physician & Payer Forum report entitled Breast Cancer in China and South Korea: Physician and Payer Insight into Market Access Drivers also finds that, in South Korea—where drug coverage is widespread—national treatment guidelines are used by payers to inform appropriate reimbursement and are strictly monitored and enforced. South Korean payers express concerns about the future escalating cost of treatments for breast cancer, particularly the combination of premium-priced agents, despite their potential efficacy benefits.

According to interviewed payers in China, the large patient population size prevents breast cancer agents with a high price tag from achieving inclusion on the national formulary. While some regional formularies can choose to reimburse premium-priced therapies, they only cover a proportion of treatment costs, placing significant financial burden on patients.

"The barriers to market access in China and South Korea are contrasting," said Decision Resources Principal Analyst Amy Duval, M.Res. "In China, premium-priced agents are not covered on national formularies as the budgets cannot accommodate the number of patients who would be eligible for treatment. In South Korea, however, high cost agents for breast cancer have typically been admitted for reimbursement, although there is strict monitoring of how they are prescribed, and increasing cost pressures on payers mean that this monitoring is likely to become even more intense. Getting the payer value messaging right, so that the product is optimally positioned in terms of the specifics of NHI reimbursement, will be increasingly important in the future."  

About Decision Resources
Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources Group company.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Surveyed EU5 Oncologists Plan Increased Uptake of Perjeta for HER2-Positive Breast Cancer, But Expect Reimbursement Hurdles for Perjeta Plus Kadcycla
2. NxStage Urges CMS to Fix Training Reimbursement to Provide Medicare Patients Greater Access to Life-Changing Home Hemodialysis Therapies
3. Efficacy Advantages and Long-Term Cost Savings Will Help Optimize Reimbursement in the EU5 for Type 2 Diabetes Agents
4. Pricing and Reimbursement in Russia
5. The Majority of Surveyed Oncologists Prescribe Avastin Off-label to Their Ovarian Cancer Patients; However Approximately Half Encounter Access and Reimbursement Hurdles
6. Approval for One Neuropathic Pain Indication is Sufficient to Support Physician Prescribing and Payer Reimbursement Across Multiple Neuropathic Pain Populations
7. Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market
8. NCPA Endorses Bipartisan Bill to Address Egregious Pharmacy Audit, Reimbursement Tactics in Medicare
9. Frost & Sullivan: Growing Reimbursement Challenges Force Hospitals to Reengineer Revenue Cycle Management
10. Reimbursement Cuts Will Challenge Japanese Interventional Cardiology Device Market
11. Home Hemodialysis Patients Urge Medicare to Fix HHD Training Reimbursement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... 27, 2017 To mark the end of Save ... a leader in digital imaging solutions, will showcase Canon eye ... at New York,s Jacob Javits Center ... Month, sponsored by the American Optometric Association, is observed annually ... receiving comprehensive eye exams. In recognition of this observance, Canon ...
(Date:3/27/2017)... March 27, 2017 FinancialBuzz.com News Commentary  ... According to a new report by Arcview ... , grew 34 percent to $6.7 billion and can be expected ... over the next five years, from $6.7 billion in 2016, to $22.6 ... will be able to purchase cannabis without a doctor,s recommendation. Voters in ...
(Date:3/27/2017)... March 27, 2017  BERG, a biopharmaceutical ... biological research approach, today announced that the ... discovery of new data using a cold-induced ... fat metabolism. Joslin Diabetes Center led the ... platform for analysis of samples.  The findings ...
Breaking Medicine Technology:
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... ability to gain site attention and engagement over the household brands of Top-20 ... webinar will discuss how partnering with the right outsourcing payments provider can ...
(Date:3/27/2017)... , ... March 27, 2017 , ... A study by ... MD, and his colleague, Sudeep Roy, MD, was recently published in the American ... Efficacy in Rhytidectomy” details Drs. Buckingham and Roy’s study on the use of Electro ...
(Date:3/27/2017)... ... March 27, 2017 , ... Buzzies parent company, The TouchPoint Solution’s ... the Runway Foundation and UBS’ Project Entrepreneur. Mayo will present her pitch about the ... , Project Entrepreneur’s second annual venture competition ignites bold ideas by providing women access ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... CE Certificate of Conformity for the Smart System® 20/20. CE Certification builds upon ... industry standards and specifications such as ANSI, ISO and proven test methods used ...
(Date:3/27/2017)... NJ (PRWEB) , ... March 27, 2017 , ... ... of cutting-edge news, research and conference coverage on veterinary medicine, announces the launch ... inaugural issue will be packaged with the April edition of American Veterinarian™. ...
Breaking Medicine News(10 mins):